Regulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancer
Open Access
- 29 August 2013
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 4 (10) , 1673-1685
Abstract
Histone variants seem to play a major role in gene expression regulation. In prostate cancer, H2A.Z and its acetylated form are implicated in oncogenes’ upregulation. SIRT1, which may act either as tumor suppressor or oncogene, reduces H2A.Z levels in cardiomyocytes, via proteasome-mediated degradation, and this mechanism might be impaired in prostate cancer cells due to sirtuin 1 downregulation. Thus, we aimed to characterize the mechanisms underlying H2A.Z and SIRT1 deregulation in prostate carcinogenesis and how they interact.Keywords
This publication has 50 references indexed in Scilit:
- Accelerating cancer evolution: a dark side of SIRT1 in genome maintenanceOncotarget, 2012
- Gene Reactivation by 5-Aza-2′-Deoxycytidine–Induced Demethylation Requires SRCAP–Mediated H2A.Z Insertion to Establish Nucleosome Depleted RegionsPLOS Genetics, 2012
- Epigenetics in Prostate Cancer: Biologic and Clinical RelevanceEuropean Urology, 2011
- Molecular genetics of prostate cancer: new prospects for old challengesGenes & Development, 2010
- Histone Variant H2A.Z Can Serve as a New Target for Breast Cancer TherapyCurrent Medicinal Chemistry, 2010
- SIRT1, Is It a Tumor Promoter or Tumor Suppressor?International Journal of Biological Sciences, 2009
- Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant MiceCancer Cell, 2008
- p53 Activation: A Case against SirCancer Cell, 2008
- Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progressionMolecular Systems Biology, 2008
- Histone H2A.z Is Essential for Cardiac Myocyte Hypertrophy but Opposed by Silent Information Regulator 2αJournal of Biological Chemistry, 2006